ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 21 filers reported holding ARMATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | +200.0% | 2 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | -33.3% | 2 | 0.0% | 0.00% | – |
| Q1 2023 | $3 | -82.4% | 2 | -85.7% | 0.00% | – |
| Q4 2022 | $17 | – | 14 | +1300.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 1,071 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -16.7% | 1,071 | -1.3% | 0.00% | – |
| Q4 2021 | $6,000 | +50.0% | 1,085 | -5.1% | 0.00% | – |
| Q3 2021 | $4,000 | -50.0% | 1,143 | -42.6% | 0.00% | – |
| Q2 2021 | $8,000 | -20.0% | 1,992 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | +66.7% | 1,992 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | 0.0% | 1,992 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | -25.0% | 1,992 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | +33.3% | 1,992 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 1,992 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | -25.0% | 1,992 | -10.6% | 0.00% | – |
| Q3 2019 | $8,000 | +700.0% | 2,227 | +1457.3% | 0.00% | – |
| Q2 2019 | $1,000 | – | 143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 113,682 | $442,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 17,550 | $68,000 | 0.01% |
| SYNOVUS FINANCIAL CORP | 47,903 | $187,000 | 0.00% |
| Edgewood Management | 100,000 | $389,000 | 0.00% |
| ROYAL BANK OF CANADA | 43 | $0 | 0.00% |
| VANGUARD GROUP INC | 273,150 | $1,062,000 | 0.00% |
| UBS Group AG | 3,131 | $12,000 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $2,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 13,072 | $51,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 634,530 | $2,468,000 | 0.00% |